AAMU
ABMD

Amundi Asset Management US’s Abiomed Inc ABMD Stock Holding History

Amundi Asset Management US’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$56.2M Sell
176,418
-26,000
-13% -$8.32M 0.04% 383
2020
Q4 		$65.6M Sell
202,418
-102,273
-34% -$28.3M 0.06% 333
2020
Q3 		$84.4M Buy
304,691
+14,704
+5% +$4.24M 0.09% 230
2020
Q2 		$70M Buy
289,987
+59,528
+26% +$12M 0.08% 251
2020
Q1 		$33.5M Sell
230,459
-27,026
-10% -$4.49M 0.06% 294
2019
Q4 		$43.9M Sell
257,485
-283,599
-52% -$52.6M 0.05% 347
2019
Q3 		$96.3M Sell
541,084
-215,404
-28% -$46.6M 0.14% 162
2019
Q2 		$197M Buy
756,488
+108,282
+17% +$28.7M 0.16% 136
2019
Q1 		$185M Buy
648,206
+491,750
+314% +$163M 0.26% 92
2018
Q4 		$50.9K Buy
156,456
+58,362
+59% +$20.3M 0.05% 252
2018
Q3 		$44.1M Buy
98,094
+4,788
+5% +$1.89M 0.06% 316
2018
Q2 		$38.2M Buy
93,306
+23,751
+34% +$8.6M 0.06% 336
2018
Q1 		$20.2M Buy
69,555
+4,527
+7% +$1.15M 0.03% 475
2017
Q4 		$12.2M Buy
+65,028
New +$12.1M 0.02% 624

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Amundi Asset Management US's ABMD Position: Q1 2021 in Review

Amundi Asset Management US reduced its Abiomed Inc (ABMD) stake by 13% in Q1 2021, selling an estimated $8.32M and leaving 176,418 shares worth $56.2M. The position accounts for 0.04% of the portfolio, ranked #383.

Amundi Asset Management US first reported a position in ABMD in Q4 2017 and has held it in 14 quarters since. The position peaked at $197M in Q2 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Amundi Asset Management US held 176,418 shares of Abiomed Inc worth $56.2M as of Q1 2021.
  • Amundi Asset Management US sold 26,000 Abiomed Inc shares in Q1 2021, an estimated $8.32M.
  • Abiomed Inc made up 0.04% of Amundi Asset Management US's portfolio in Q1 2021, its #383 holding.
  • Amundi Asset Management US first reported a position in Abiomed Inc in Q4 2017 and has held it in 14 quarters since.
  • Amundi Asset Management US's Abiomed Inc position peaked at $197M in Q2 2019.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.